Savant Capital LLC Purchases 16,538 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Savant Capital LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 149.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 27,585 shares of the company’s stock after purchasing an additional 16,538 shares during the period. Savant Capital LLC’s holdings in GE HealthCare Technologies were worth $2,157,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in GEHC. LGT Financial Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $31,000. Finally, Continuum Advisory LLC boosted its stake in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently commented on GEHC. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $96.77.

GE HealthCare Technologies Trading Down 1.3 %

GE HealthCare Technologies stock opened at $85.90 on Thursday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock has a market cap of $39.25 billion, a PE ratio of 23.60, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The stock has a 50-day moving average of $83.58 and a two-hundred day moving average of $85.39. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.55.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.